EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Discovery of Novel Thiazole-Based SIRT2 Inhibitors as Anticancer Agents: Molecular Modeling, Chemical Synthesis and Biological Assays

Francesco Piacente iD, Giorgia Guccione iD, Naomi Scarano iD, Dario Lunaccio iD, Caterina Miro iD, Elena Abbotto iD, Annalisa Salis iD, Bruno Tasso iD, Monica Dentice iD, Santina Bruzzone iD, Elena Cichero, Enrico Millo iD

International Journal of Molecular Sciences · 2024

DOI: 10.3390/ijms252011084 ↗

Kurz gefasst

Fachartikel in der Zeitschrift International Journal of Molecular Sciences, 2024. Verfasst von Francesco Piacente und 11 weiteren Autor:innen. Beteiligte Einrichtung: Department of Experimental Medicine, Section of Biochemistry, University of Genoa, Viale Benedetto XV, 1, 16132 Genoa, Italy. Hauptthemen laut MEDLINE: Sirtuin 2, Thiazoles, Antineoplastic Agents, Molecular Docking Simulation. Die Arbeit wurde bisher 8-mal zitiert (Crossref) und nennt 50 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: European Union's Horizon 2020 research and innovation program - Marie Skłodow-ska-Curie, University of Genova, University of Genoa.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

The search and development of effective sirtuin small molecule inhibitors (SIRTIs) continues to draw great attention due to their wide range of pharmacological applications. Based on SIRTs’ involvement in different biological pathways, their ligands were investigated for many diseases, such as cancer, neurodegenerative disorders, diabetes, cardiovascular diseases and autoimmune diseases. The elucidation of a substantial number of SIRT2–ligand complexes is steering the identification of novel and more selective modulators. Among them, SIRT2 in the presence of the SirReal2 analog series was the most studied. On this basis, we recently reported structure-based analyses leading to the discovery of thiazole-based compounds acting as SIRT2 inhibitors (T1, SIRT2 IC50 = 17.3 µM). Herein, ligand-based approaches followed by molecular docking simulations allowed us to evaluate in silico a novel small series of thiazoles (3a–3d and 5a, 5d) as putative SIRT2 inhibitors. Results from the computational studies revealed comparable molecular interaction fields (MIFs) and docking positionings of most of these compounds with respect to reference SIRT2Is. Biochemical and biological assays validated this study and pointed to compound 5a (SIRT2 IC50 = 9.0 µM) as the most interesting SIRT2I that was worthy of further development as an anticancer agent.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Sirtuin 2ThiazolesAntineoplastic AgentsMolecular Docking SimulationHumansStructure-Activity RelationshipDrug DiscoveryModels, MolecularLigandsCell Line, Tumor

Stichwörter der Autor:innen

SIRT2biochemical assayscancerdrug designenzymatic assaysinhibitormolecular dockingsirtuin

Substanzen

Sirtuin 2ThiazolesAntineoplastic AgentsSIRT2 protein, humanLigands

Autor:innen und Institutionen

  • Department of Experimental Medicine, Section of Biochemistry, University of Genoa, Viale Benedetto XV, 1, 16132 Genoa, Italy.
  • Department of Pharmacy, Section of Medicinal Chemistry, School of Medical and Pharmaceutical Sciences, University of Genoa, Viale Benedetto XV, 3, 16132 Genoa, Italy.
  • Department of Clinical Medicine & Surgery, University of Naples Federico II, Via S. Pansini, 5, 80131 Naples, Italy.
  • IRCCS Ospedale Policlinico San Martino, Largo Rosanna Benzi 10, 16132 Genoa, Italy.

ORCID-Profile: Francesco Piacente, Giorgia Guccione, Naomi Scarano, Dario Lunaccio, Caterina Miro, Elena Abbotto, Annalisa Salis, Bruno Tasso, Monica Dentice, Santina Bruzzone, Enrico Millo

Förderung

  • European Union's Horizon 2020 research and innovation program - Marie Skłodow-ska-Curie
  • University of Genova
  • University of Genoa
  • Marie Skłodowska-Curie

Zitieren

APA

Piacente, F., Guccione, G., Scarano, N., Lunaccio, D., Miro, C., Abbotto, E., Salis, A., Tasso, B., Dentice, M., Bruzzone, S., Cichero, E., & Millo, E. (2024). Discovery of Novel Thiazole-Based SIRT2 Inhibitors as Anticancer Agents: Molecular Modeling, Chemical Synthesis and Biological Assays. International Journal of Molecular Sciences. https://doi.org/10.3390/ijms252011084

Vancouver

Piacente F, Guccione G, Scarano N, Lunaccio D, Miro C, Abbotto E, et al. Discovery of Novel Thiazole-Based SIRT2 Inhibitors as Anticancer Agents: Molecular Modeling, Chemical Synthesis and Biological Assays. International Journal of Molecular Sciences. 2024. doi:10.3390/ijms252011084

BibTeX
@article{Piacente2024,
  author = {Piacente, Francesco and Guccione, Giorgia and Scarano, Naomi and Lunaccio, Dario and Miro, Caterina and Abbotto, Elena and Salis, Annalisa and Tasso, Bruno and Dentice, Monica and Bruzzone, Santina and Cichero, Elena and Millo, Enrico},
  title = {Discovery of Novel Thiazole-Based SIRT2 Inhibitors as Anticancer Agents: Molecular Modeling, Chemical Synthesis and Biological Assays},
  journal = {International Journal of Molecular Sciences},
  year = {2024},
  doi = {10.3390/ijms252011084}
}
Kostenlos starten →